Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesThe molecular mechanism of etanercept, an anti-tumour necrosis factor-a receptor-fusion protein, in the treatment of acute generalized exanthematous pustulosis
Journal of Dermatological Treatment , 08/14/09
Gencoglan G et al. – Because TNF–alpha stimulated inflammation and also p53–related apoptosis occurs in AGEP, a TNF–alpha blocking agent such as etanercept may be effective for quick treatment.
Related Articles
SAPHO syndrome: is a range of pathogen-associated rheumatic diseases extended
Arthritis Research & Therapy, 11/17/09
Relevance Score: 42%
Therapeutic options for palmoplantar pustulosis
Clinical and Experimental Dermatology, 11/16/09
Relevance Score: 42%
Extra-palmoplantar lesions associated with palmoplantar pustulosis
Journal of the European Academy of Dermatology and Venereology, 10/26/09
Relevance Score: 40%
A case of SAPHO syndrome with destructive spondylodiscitis suspicious of tuberculous spondylitis
Modern Rheumatology, 10/23/09
Relevance Score: 40%
New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome
Current Rheumatology Reports, 10/09/09
Relevance Score: 40%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Weight Gain and Insulin Resistance in Children Treated With Valproate: The Influence of Time
Journal of Child Neurology, 03/19/10
Ranolazine-related dyspnea on exertion
The American Journal of Geriatric Pharmacotherapy, 03/19/10
A review of the effect of anticonvulsant medications on bone mineral density and fracture risk
The American Journal of Geriatric Pharmacotherapy, 03/19/10
Article Search
Sponsor
Sponsor